U.S. Federal Trade Commission: FTC approves final order settling charges that Grifols, S.A.’s acquisition of Talecris Biotherapeutics Holding Corp. was anticompetitive
MLex Summary: The Federal Trade Commission has issued this statement approving its final order, after the closing of the comment period, settling charges that Grifols' acquisition of Talecris was anticompetitive and...To view the full article, register now.
Already a subscriber? Click here to view full article